Drawing for PERLARA

USPTO serial 87225733

PERLARA

Reviewed by CopyMark Law Group

Reg. 5218445Status 702Renewal
Filing date
Status date
Registration date
Jun 6, 2017
Examiner
WELLS, KELLEY L
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with PERLARA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Diana Rutowski & Seth Reagan

Diana Rutowski & Seth Reagan ORRICK, HERRINGTON & SUTCLIFFE LLP2050 MAIN ST., SUITE 1100IRVINE, CA 92614United States

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical research services; Pharmaceutical research and development; Pharmaceutical research into new drugs and development of drugs; Development of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical drug development services; Research and development of pharmaceutical preparations and medicines; Pharmaceutical research services, namely, research in new treatments to treat rare diseases; Pharmaceutical research and development, namely, research and development of new treatments to treat rare diseases; Pharmaceutical research into new drugs and development of drugs to treat rare diseases; Development of pharmaceutical preparations and medicines to treat rare diseases; Research and development of pharmaceutical preparations and medicines to treat rare diseases; Providing a website featuring information about pharmaceutical research into new drugs and development of drugsACTIVESep 22, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 10, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 10, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 10, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 5, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Jun 6, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 6, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 6, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 28, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 6, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 9, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 9, 2017DOCKASSIGNED TO EXAMINER—
Nov 8, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 7, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance